Director TitleAgeSince
Director/Board Member - 01/10/2010
Director/Board Member - 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
-0.31%-2.29%+22.57%+69.33% 49.03B
+4.40%+14.46%+62.66%+133.25% 42.33B
-0.89%-0.64%-1.48%+15.58% 12.43B
+0.56%-1.12%+19.02%+70.02% 11.68B
+0.19%+0.77%+31.74%+141.01% 9.12B
+1.99%+4.41%+17.56%+34.79% 7.15B
+1.82%-0.15%+39.41%-13.77% 7.09B
+0.40%+2.02%+12.85%+176.30% 6.76B
+6.44%+8.26%-24.61%+30.64% 5.95B
Average +17,991.46%+2.74%+19.97%+73.02% 16.84B
Weighted average by Cap. +1.76%+3.75%+30.34%+84.87%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock